Treatment Advances

July 02, 2025

Learn how the FDA’s decision to remove safety restrictions for CAR T-cell therapy could improve access for people with blood cancer.

July 02, 2025

Learn about the newly approved bispecific antibody for myeloma called linvoseltamab. Discover if this treatment is right for your care.

July 01, 2025

In vivo CAR T therapy may make blood cancer treatment safer, faster, and more accessible.

June 23, 2025

Learn how cilta-cel CAR T-cell therapy improves long-term outcomes for people with multiple myeloma, based on CARTITUDE trial data.

June 17, 2025

Learn how talquetamab and teclistamab together performed in a study of patients with relapsed or refractory myeloma with extramedullary disease.

June 05, 2025

New studies support faster, subcutaneous Sarclisa delivery using an on-body injector with similar results to IV treatment.

May 22, 2025

Discover why the FDA panel supported daratumumab therapy for high-risk smoldering multiple myeloma and what this means for patient care and progression.

May 20, 2025

Study shows 3-drug combo may reduce GvHD risk after stem cell transplant, improving survival and lowering relapse rates.

May 19, 2025

New gene discovery may explain why some myeloma therapies stop working and guide future personalized treatment options.

May 16, 2025

ISB 2001 shows strong response and safety in early trial for relapsed/refractory multiple myeloma after prior treatment failure.